Health ❯ Healthcare ❯ Pharmacology

Drug Efficacy

Beta-blocker Efficacy RSV Treatments Protease Activators Beta Blockers in Heart Patients Ketamine Dulaglutide Firmonertinib Objective Response Rate Clinical Trials Zongertinib

Trials Recast Post–Heart Attack Beta-Blocker Use, With Signal of Harm in Women

Fresh randomized results highlight differing effects by ejection fraction, challenging automatic prescriptions after uncomplicated infarction.